TiliROSide 是糖苷类黄酮，是 α-淀粉酶的非竞争性抑制剂(Ki:84.2 μM)。它抑制胃肠道中碳水化合物的消化和葡萄糖的吸收，具有抗糖尿病作用。

1. Potengriffioside A shows anticarcinogenic activity. 2. Potengriffioside A shows hepatoprotective activity. 3. Potengriffioside A shows antioxidant and anti-inflammatory activity, can inhibit neuroinflammation in neurodegenerative disorders. 4. Potengriffioside A has anti-diabetic effect, are at least partially mediated through inhibitory effects on carbohydrate digestion and glucose uptake in the gastrointestinal tract. 5. Potengriffioside A and gnaphaliin are antioxidants against in vitro Cu(2+)-induced LDL oxidation in the same order of magnitude compared to that of the reference drug, probucol. 6. Potengriffioside A enhances fatty acid oxidation via the enhancement adiponectin signaling associated with the activation of both AMP-activated protein kinase and peroxisome proliferator-activated receptor α and ameliorates obesity-induced metabolic disorders.

20316-62-5

C30H26O13

594.525

银椴甙;银椴苷；椴树苷;Tribuloside

DMSO:10mM
Powder: -20°C for 3 years
In solvent: -80°C for 2 years